Bioscience will serve as the exclusive UK and Ireland distributor for Bio X Cell’s premium monoclonal antibody portfolio. The strategic partnership aims to enhance researcher access to high-quality functional antibodies across academic and biotech institutions throughout both regions.

Europa Biosite has strengthened its market position through a new exclusive distribution agreement that brings Bio X Cell’s renowned monoclonal antibody portfolio to UK and Ireland researchers via Cambridge Bioscience.
The partnership leverages Cambridge Bioscience’s four-decade track record in life science distribution, including established relationships with prestigious institutions such as the University of Cambridge, University of Oxford, University College London, and Trinity College Dublin. This collaboration expands Europa Biosite’s existing Nordic and Swiss distribution network for Bio X Cell products.

High-quality reagents for sensitive applications

Bio X Cell’s antibody portfolio has earned global recognition for its exceptional quality, purity, and consistency across in vivo, ex vivo, and new approach methodologies (NAMs) studies. These characteristics prove essential for researchers conducting sensitive biomedical investigations where reagent reliability directly impacts experimental outcomes. Sune Schmolker, CEO of Europa Biosite, emphasised the significance of this expansion: “We have for many years distributed the innovative and well-documented antibodies of Bio X Cell in Nordics and Switzerland, and I am very pleased in the trust put in us expanding our collaboration into UK and Ireland.”

Strategic market expansion

Christopher Conway, CEO of Bio X Cell, highlighted the partnership’s research-focused approach: “Bio X Cell’s partnership with Cambridge Bioscience deepens our expertise and commitment to enabling global research with the highest quality functional antibodies.” The agreement positions Cambridge Bioscience as the single point of access for Bio X Cell products across UK and Irish markets, streamlining procurement processes for research institutions and biotech companies requiring premium antibody reagents for critical studies.

For more information, visit: https://shorturl.at/kZOeG